Surgical Outcomes of Conventional Hysterectomy or Manipulator-assisted Abdominal Hysterectomy
Launched by DR. LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL · Apr 16, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Inclusion criteria were patients aged 40-70 years who underwent hysterectomy for benign gynecological indications
- Exclusion Criteria:
- • Exclusion criteria were patients with additional procedures such as urogynecologic procedures, history of abdominal surgery with midline incision, patients with suspected gynecologic malignancy, endometriosis, tubo-ovarian abscess, pelvic organ prolapse, or those who refused to participate in the study and whose medical records could not be obtained.
About Dr. Lutfi Kirdar Kartal Training And Research Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. Located in Kartal, Istanbul, the hospital combines state-of-the-art facilities with a commitment to education and training, fostering an environment where medical professionals can collaborate on groundbreaking studies. With a focus on various therapeutic areas, the hospital actively sponsors clinical trials aimed at enhancing treatment methodologies and contributing to the global medical community. Through rigorous protocols and ethical practices, Dr. Lutfi Kirdar Kartal Training and Research Hospital plays a vital role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported